Cizutamig Human Monoclonal Antibody
Cizutamigis a research-grade recombinant antibody targeting CD269. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Tumor necrosis factor receptor superfamily member 17, B-cell maturation protein, CD269, TNFRSF17, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E
UniProt
Q02223, P07766
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
Fab-IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-3165R-PE 100 µL
Phospho-Gab1 (Tyr627) Polyclonal Antibody, PE Conjugated
Sign In for Pricing
View Details 
GTR15395787 1 Vial
Lentiviral human CD80 sgRNA gene knockout kit - Lentiviral human CD80 sgRNA gene knockout kit (25)
Sign In for Pricing
View Details